login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AGENUS INC (AGEN) Stock News
USA
- NASDAQ:AGEN -
US00847G8042
-
Common Stock
4.125
USD
-0.11 (-2.48%)
Last: 11/19/2025, 11:23:46 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AGEN Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
AGENUS INC (NASDAQ:AGEN) Reports Mixed Q3 2025 Earnings, Driven by One-Time Gain
a day ago - By: Agenus Inc.
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC
9 days ago - By: Zacks Investment Research
- Mentions:
ARMP
Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
9 days ago - By: Agenus Inc.
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
12 days ago - By: Benzinga
Insights Ahead: Agenus's Quarterly Earnings
13 days ago - By: Zacks Investment Research
- Mentions:
NTLA
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates
14 days ago - By: Zacks Investment Research
- Mentions:
INVA
Innoviva (INVA) Q3 Earnings and Revenues Beat Estimates
14 days ago - By: Agenus Inc.
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
16 days ago - By: Zacks Investment Research
- Mentions:
SRPT
Sarepta Therapeutics (SRPT) Reports Q3 Loss, Beats Revenue Estimates
a month ago - By: Agenus Inc.
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
a month ago - By: Agenus Inc.
Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights
2 months ago - By: Agenus Inc.
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
3 months ago - By: Agenus, Inc.
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Agenus Inc.
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
3 months ago - By: Agenus Inc.
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
3 months ago - By: Zacks Investment Research
- Mentions:
INO
Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: The Motley Fool
Agenus Posts 48% Q2 Revenue Miss
3 months ago - By: Agenus Inc.
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
3 months ago - By: Benzinga
Examining the Future: Agenus's Earnings Outlook
3 months ago - By: Zacks Investment Research
- Mentions:
GILD
Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
ANAB
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
CVEO
QS
Zacks.com featured highlights include QuantumScape, Civeo and Agenus
4 months ago - By: Agenus Inc.
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report
4 months ago - By: Agenus Inc.
Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025
5 months ago - By: Agenus Inc.
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
5 months ago - By: Agenus Inc.
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
5 months ago - By: Yahoo Finance
- Mentions:
TIXT
TINT
TU
CLVT
TELUS International (Cda) Inc. (TIXT) Surges 27% Following Buyout Proposal from TELUS Corporation
5 months ago - By: Yahoo Finance
- Mentions:
SNYR
SYNR
MKL
BTG
...
Here is What You Need to Know Before Investing in Synergy CHC Corp. (SNYR)
5 months ago - By: Yahoo Finance
- Mentions:
HON
ITGR
TTEK
FSS
...
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock
5 months ago - By: Agenus Inc.
Agenus Announces Virtual Annual Shareholders Meeting
Please enable JavaScript to continue using this application.